Setterwalls assisted SynAct Pharma AB on the deal. SynAct has carried out a private placement of shares and warrants to an entity managed by Heights Capital...
You must be a Standard 1 Year member to access this content.
Setterwalls has assisted SynAct Pharma AB in the transaction. SynAct Pharma AB announced the acquisition of the Swiss-incorporated biotech company TXP Pharma AG. The acquisition encompasses...
You must be a Standard 1 Year member to access this content.
Baker McKenzie acted as legal advisor to the banks. Setterwalls has assisted SynAct Pharma. In connection with the acquisition of TXP, SynAct has also carried out...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised SynAct Pharma AB. SynAct Pharma AB announced the listing of the company’s shares on Nasdaq Stockholm, Mid Cap. The trading on Nasdaq Stockholm commenced...
You must be a Standard 1 Year member to access this content.
Baker McKenzie acted as legal advisor to the Joint Global Coordinators with an international Capital Markets, while Setterwalls has advised SynAct Pharma AB . SynAct Pharma...
You must be a Standard 1 Year member to access this content.
